[1]

Jimenez-Gonzalez A, Ansaloni F, Nebendahl C, Alavioon G, Murray D, et al. 2024. Paternal starvation affects metabolic gene expression during zebrafish offspring development and lifelong fitness. Molecular Ecology 33(6):e17296

doi: 10.1111/mec.17296
[2]

Nakanishi S, Inoue A, Kita T, Nakamura M, Chang AC, et al. 1979. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature 278(5703):423−427

doi: 10.1038/278423a0
[3]

Tatemoto K, Carlquist M, Mutt V. 1982. Neuropeptide Y — a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296(5858):659−660

doi: 10.1038/296659a0
[4]

Shutter JR, Graham M, Kinsey AC, Scully S, Lüthy R, et al. 1997. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes & Development 11(5):593−602

doi: 10.1101/gad.11.5.593
[5]

Wu H, Li J, Jiang K, Li Y, Yu Z, et al. 2025. Characterization of leptin and leptin receptor gene in the Siberian sturgeon (Acipenser baerii): molecular cloning, tissue distribution, and its involvement in feeding regulation. International Journal of Molecular Sciences 26(5):1968

doi: 10.3390/ijms26051968
[6]

Tang N, Li Y, Li Y, Xu S, Wang M, et al. 2024. Motilin, a novel orexigenic factor, involved in feeding regulation in Yangtze sturgeon (Acipenser dabryanus). Biomolecules 14(4):433

doi: 10.3390/biom14040433
[7]

Willesen MG, Kristensen P, Rømer J. 1999. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70(5):306−316

doi: 10.1159/000054491
[8]

Yokogi K, Goto Y, Otsuka M, Ojima F, Kobayashi T, et al. 2022. Neuromedin U-deficient rats do not lose body weight or food intake. Scientific reports 12(1):17472

doi: 10.1038/s41598-022-21764-6
[9]

Vallöf D, Kalafateli AL, Jerlhag E. 2020. Brain region-specific neuromedin U signalling regulates alcohol-related behaviours and food intake in rodents. Addiction Biology 25(3):e12764

doi: 10.1111/adb.12764
[10]

Ghashghayi E, Zendehdel M, Khodadadi M, Rahmani B. 2024. Central dopaminergic, serotoninergic, as well as GABAergic systems mediate NMU-induced hypophagia in newborn chicken. The International journal of neuroscience 134(4):353−363

doi: 10.1080/00207454.2022.2102980
[11]

Zhang X, Chen S, Tang N, Wang S, Liu Y, et al. 2023. Neuromedin U regulates food intake of Siberian sturgeon through the modulation of central and peripheral appetite factors. The British journal of nutrition 129(5):904−918

doi: 10.1017/S0007114522001696
[12]

Botticelli L, Micioni Di Bonaventura E, Del Bello F, Giorgioni G, Piergentili A, et al. 2023. The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior. Pharmacological research 195:106875

doi: 10.1016/j.phrs.2023.106875
[13]

Austin C, Lo G, Nandha KA, Meleagros L, Bloom SR. 1995. Cloning and characterization of the cDNA encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal tract. Journal of Molecular Endocrinology 14(2):157−169

doi: 10.1677/jme.0.0140157
[14]

Kojima M, Haruno R, Nakazato M, Date Y, Murakami N, et al. 2000. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochemical and Biophysical Research Communications 276(2):435−438

doi: 10.1006/bbrc.2000.3502
[15]

Szekeres PG, Muir AI, Spinage LD, Miller JE, Butler SI, et al. 2000. Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. The Journal of Biological Chemistry 275(27):20247−20250

doi: 10.1074/jbc.C000244200
[16]

Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Habata Y, et al. 2000. Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. The Journal of Biological Chemistry 275(28):21068−21074

doi: 10.1074/jbc.M001546200
[17]

Howard AD, Wang R, Pong SS, Mellin TN, Strack A, et al. 2000. Identification of receptors for neuromedin U and its role in feeding. Nature 406(6791):70−74

doi: 10.1038/35017610
[18]

Brighton PJ, Szekeres PG, Willars GB. 2004. Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacological Reviews 56(2):231−248

doi: 10.1124/pr.56.2.3
[19]

Funes S, Hedrick JA, Yang S, Shan L, Bayne M, et al. 2002. Cloning and characterization of murine neuromedin U receptors. Peptides 23(9):1607−1615

doi: 10.1016/s0196-9781(02)00097-9
[20]

Mohammed EA, Ma ZY, Lei ZH. 2017. cDNA cloning and distribution of neuromedin U and its receptor in the rabbit. Journal of Veterinary Science & Medical Diagnosis 6(2):1−8

doi: 10.4172/2325-9590.1000225
[21]

Li X, Niu M, Su J, Ma Z, Jin M, et al. 2017. Cloning and expression patterns of neuromedin U and its receptors in pigs. Neuropeptides 64:47−60

doi: 10.1016/j.npep.2017.04.003
[22]

Wan Y, Zhang J, Fang C, Chen J, Li J, et al. 2018. Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens. Peptides 101:69−81

doi: 10.1016/j.peptides.2017.12.022
[23]

Maruyama K, Kaiya H, Miyazato M, Konno N, Wakasugi T, et al. 2011. Isolation and characterisation of two cDNAs encoding the neuromedin U receptor from goldfish brain. Journal of Neuroendocrinology 23(3):282−291

doi: 10.1111/j.1365-2826.2010.02106.x
[24]

Chiu CN, Rihel J, Lee DA, Singh C, Mosser EA, et al. 2016. A zebrafish genetic screen identifies neuromedin U as a regulator of sleep/wake states. Neuron 89(4):842−856

doi: 10.1016/j.neuron.2016.01.007
[25]

Raddatz R, Wilson AE, Artymyshyn R, Bonini JA, Borowsky B, et al. 2000. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. The Journal of Biological Chemistry 275(42):32452−32459

doi: 10.1074/jbc.M004613200
[26]

Graham ES, Turnbull Y, Fotheringham P, Nilaweera K, Mercer JG, et al. 2003. Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status. Journal of Neurochemistry 87(5):1165−1173

doi: 10.1046/j.1471-4159.2003.02079.x
[27]

Maruyama K, Konno N, Ishiguro K, Wakasugi T, Uchiyama M, et al. 2008. Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and the inhibitory effect of a deduced NMU on food intake and locomotor activity. Journal of Neuroendocrinology 20(1):71−78

doi: 10.1111/j.1365-2826.2007.01615.x
[28]

McCue DL, Kasper JM, Hommel JD. 2017. Regulation of motivation for food by neuromedin U in the paraventricular nucleus and the dorsal raphe nucleus. International journal of obesity 41(1):120−128

doi: 10.1038/ijo.2016.178
[29]

Peier AM, Desai K, Hubert J, Du X, Yang L, et al. 2011. Effects of peripherally administered neuromedin U on energy and glucose homeostasis. Endocrinology 152(7):2644−2654

doi: 10.1210/en.2010-1463
[30]

Vallöf D, Ulenius L, Egecioglu E, Engel JA, Jerlhag E. 2017. Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol-induced reward in rodents. Addiction Biology 22(3):640−51

doi: 10.1111/adb.12355
[31]

Westfall TD, McCafferty GP, Pullen M, Gruver S, Sulpizio AC, et al. 2002. Characterization of neuromedin U effects in canine smooth muscle. The Journal of Pharmacology and Experimental Therapeutics 301(3):987−992

doi: 10.1124/jpet.301.3.987
[32]

Peier A, Kosinski J, Cox-York K, Qian Y, Desai K, et al. 2009. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2). Endocrinology 150(7):3101−3109

doi: 10.1210/en.2008-1772
[33]

Egecioglu E, Ploj K, Xu X, Bjursell M, Salomé N, et al. 2009. Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice. American Journal of Physiology - Endocrinology and Metabolism 297(3):E708−E716

doi: 10.1152/ajpendo.91022.2008
[34]

Kaisho T, Nagai H, Asakawa T, Suzuki N, Fujita H, et al. 2017. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice. International journal of obesity 41:1790−1797

doi: 10.1038/ijo.2017.176
[35]

Sampson CM, Kasper JM, Felsing DE, Raval SR, Ye N, et al. 2018. Small-molecule neuromedin U receptor 2 agonists suppress food intake and decrease visceral fat in animal models. Pharmacology Research & Perspectives 6:e00425

doi: 10.1002/prp2.425
[36]

Fang L, Zhang M, Li C, Dong S, Hu Y. 2006. Chemical genetic analysis reveals the effects of NMU2R on the expression of peptide hormones. Neuroscience Letters 404(1−2):148−153

doi: 10.1016/j.neulet.2006.05.034
[37]

Takayama K, Mori K, Tanaka A, Sasaki Y, Sohma Y, et al. 2020. A chemically stable peptide agonist to neuromedin U receptor type 2. Bioorganic & Medicinal Chemistry 28(10):115454

doi: 10.1016/j.bmc.2020.115454
[38]

Tanaka A, Takayama K, Furubayashi T, Mori K, Takemura Y, et al. 2020. Transnasal delivery of the peptide agonist specific to neuromedin-U receptor 2 to the brain for the treatment of obesity. Molecular Pharmaceutics 17(1):32−39

doi: 10.1021/acs.molpharmaceut.9b00571
[39]

Chen D, Li Y, Wu H, Wu Y, Tang N, et al. 2022. Ghrelin-Ghrelin receptor (GSHR) pathway via endocannabinoid signal affects the expression of NPY to promote the food intake of Siberian sturgeon (Acipenser baerii). Hormones and Behavior 143:105199

doi: 10.1016/j.yhbeh.2022.105199
[40]

Dehal P, Boore JL. 2005. Two rounds of whole genome duplication in the ancestral vertebrate. PLoS Biology 3(10):e314

doi: 10.1371/journal.pbio.0030314
[41]

Capra V, Veltri A, Foglia C, Crimaldi L, Habib A, et al. 2004. Mutational analysis of the highly conserved ERY motif of the thromboxane A2 receptor: alternative role in G protein-coupled receptor signaling. Molecular Pharmacology 66(4):880−889

doi: 10.1124/mol.104.001487
[42]

Rhee MH, Nevo I, Levy R, Vogel Z. 2000. Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor. FEBS Letters 466(2−3):300−304

doi: 10.1016/s0014-5793(00)01094-2
[43]

Perlman JH, Wang W, Nussenzveig DR, Gershengorn MC. 1995. A disulfide bond between conserved extracellular cysteines in the thyrotropin-releasing hormone receptor is critical for binding. The Journal of Biological Chemistry 270(42):24682−24685

doi: 10.1074/jbc.270.42.24682
[44]

Rosenbaum DM, Rasmussen SGF, Kobilka BK. 2009. The structure and function of G-protein-coupled receptors. Nature 459(7245):356−363

doi: 10.1038/nature08144
[45]

Moriyama M, Sato T, Inoue H, Fukuyama S, Teranishi H, et al. 2005. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells. The Journal of Experimental Medicine 202(2):217−224

doi: 10.1084/jem.20050248
[46]

Moriyama M, Fukuyama S, Inoue H, Matsumoto T, Sato T, et al. 2006. The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. American Journal of Physiology Lung Cellular and Molecular Physiology 290(5):L971−L977

doi: 10.1152/ajplung.00345.2005
[47]

Torres R, Croll SD, Vercollone J, Reinhardt J, Griffiths J, et al. 2007. Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses. Pain 130:267−278

doi: 10.1016/j.pain.2007.01.036
[48]

Li Y, Liu S, Zhou K, Wang Y, Chen Y, et al. 2023. Neuromedin U programs eosinophils to promote mucosal immunity of the small intestine. Science 381:1189−1196

doi: 10.1126/science.ade4177
[49]

Prendergast CE, Morton MF, Figueroa KW, Wu X, Shankley NP. 2006. Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice. British Journal of Pharmacology 147(8):886−896

doi: 10.1038/sj.bjp.0706677
[50]

Dass NB, Bassil AK, North-Laidler VJ, Morrow R, Aziz E, et al. 2007. Neuromedin U can exert colon-specific, enteric nerve-mediated prokinetic activity, via a pathway involving NMU1 receptor activation. British Journal of Pharmacology 150(4):502−508

doi: 10.1038/sj.bjp.0707004
[51]

Honda Y, Takagi W, Wong MKS, Ogawa N, Tokunaga K, et al. 2020. Morphological and functional development of the spiral intestine in cloudy catshark (Scyliorhinus torazame). The Journal of Experimental Biology 223:jeb225557

doi: 10.1242/jeb.225557
[52]

Wen S, Wang C, Gong M, Zhou L. 2019. An overview of energy and metabolic regulation. Science China Life Sciences 62(6):771−790

doi: 10.1007/s11427-018-9371-4
[53]

Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST. et al. 2009. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatology International 3(1):269−282

doi: 10.1007/s12072-008-9106-x
[54]

Hardy RS, Zadmajid V, Butts IAE, Litvak MK. 2021. Growth, survivorship, and predator avoidance capability of larval shortnose sturgeon (Acipenser brevirostrum) in response to delayed feeding. PLoS One 16:e0247768

doi: 10.1371/journal.pone.0247768
[55]

Furné M, Morales AE, Trenzado CE, García-Gallego M, Carmen Hidalgo M, et al. 2012. The metabolic effects of prolonged starvation and refeeding in sturgeon and rainbow trout. Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology 182(1):63−76

doi: 10.1007/s00360-011-0596-9
[56]

Wu XY, Chen YY, Lai JS, Liu Y, Song MJ, et al. 2021. Effects of starvation and refeeding on growth performance, appetite, growth hormone-insulin-like growth factor axis levels and digestive function of Acipenser dabryanus. The British Journal of Nutrition 126:695−707

doi: 10.1017/S0007114520004389
[57]

Wei R, Yuan D, Wang T, Zhou C, Lin F, et al. 2013. Characterization, tissue distribution and regulation of agouti-related protein (AgRP) in a cyprinid fish (Schizothorax prenanti). Gene 527(1):193−200

doi: 10.1016/j.gene.2013.06.003
[58]

Yuan D, Wang T, Zhou C, Lin F, Chen H, et al. 2014. Leptin and cholecystokinin in Schizothorax prenanti: molecular cloning, tissue expression, and mRNA expression responses to periprandial changes and fasting. General and Comparative Endocrinology 204:13−24

doi: 10.1016/j.ygcen.2014.05.013
[59]

Zhang X, Wu Y, Hao J, Zhu J, Tang N, et al. 2016. Intraperitoneal injection urocortin-3 reduces the food intake of Siberian sturgeon (Acipenser baerii). Peptides 85:80−88

doi: 10.1016/j.peptides.2016.09.007
[60]

Benzon CR, Johnson SB, McCue DL, Li D, Green TA, et al. 2014. Neuromedin U receptor 2 knockdown in the paraventricular nucleus modifies behavioral responses to obesogenic high-fat food and leads to increased body weight. Neuroscience 258:270−279

doi: 10.1016/j.neuroscience.2013.11.023